Aurobindo Pharma Ltd has informed BSE regarding Outcome of Board Meeting held on September 12, 2013. Inter alia, has considered the following: 1. In order to strengthen and provide focused growth to the injectables business, the Board has considered and approved the transfer of Injectables Unit IV as a going concern to Curepro Parenterals Limited,a wholly owned subsidiary of the Company pursuant to a Scheme of Arrangement. The Scheme is subject to requisite consent, approval of the shareholders, the Hon'ble High Court of Judicature at Hyderabad, Andhra Pradesh, Stock Exchanges, SEBI, the permission or approval of any other statutory or regulatory authorities, which by law may be necessary for the implementation of the Scheme.